Bacteremia Caused by Aeromonas hydrophila Complex in the Caribbean Islands of Martinique and Guadeloupe

Aeromonas species are Gram-negative bacilli of the water environment whose survival appears facilitated by warm climates. There have been no reports on Aeromonas hydrophila complex ( A. hydrophila , A. caviae , A. veronii ) in the Caribbean to date. Our aim was to describe clinical and bacteriologic...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of tropical medicine and hygiene Vol. 83; no. 5; pp. 1123 - 1127
Main Authors HOCHEDEZ, Patrick, HOPE-RAPP, Emilie, OLIVE, Claude, NICOLAS, Muriel, BEAUCAIRE, Gilles, CABIE, André
Format Journal Article
LanguageEnglish
Published Deerfield, IL American Society of Tropical Medecine and Hygiene 05.11.2010
The American Society of Tropical Medicine and Hygiene
Subjects
Bacterial diseases
Bacterial sepsis
Biological and medical sciences
Human bacterial diseases
Infectious diseases
Medical sciences
Central America
Caribbean Basin
Martinique
Guadeloupe
America
West Indies
Infection
Bacteriosis
Aeromonas hydrophila
Bacteria
Vibrionaceae
Tropical medicine
Bacteremia
Online AccessGet full text

Cover

More Information
Summary:Aeromonas species are Gram-negative bacilli of the water environment whose survival appears facilitated by warm climates. There have been no reports on Aeromonas hydrophila complex ( A. hydrophila , A. caviae , A. veronii ) in the Caribbean to date. Our aim was to describe clinical and bacteriological features in patients presenting with such bacteremia in Martinique and Guadeloupe. During a 14-year period, we retrospectively identified 37 patients. The mean age was 55 years and in 89% of cases underlying disease such as digestive diseases, cutaneous wounds, and malignancy were identified. One case was related to severe strongyloidiasis and one with snake bite. Polymicrobial bacteremia was identified in 38%, essentially with Enterobacteriaceae . All Aeromonas isolates were resistant to amoxicillin but extended-spectrum beta-lactam and fluoroquinolone were active against more than 95%. During hospitalization 10 patients died (27%). Older age, occurrence of multiorgan failure, and impaired renal function were associated with in-hospital mortality.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.2010.10-0063